Market research
23Q.F VIVO Cannabis Inc
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 6M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 2.12
Community
Investor discussion
1 comment
Sign in to join the 23Q.F discussion.
5 years, 5 months ago
VIVO Cannabis Inc is currently in a long term downtrend where the price is trading 23.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.
VIVO Cannabis Inc's total revenue rose by 13.6% to $7M since the same quarter in the previous year.
Its net income has increased by 59.0% to $-5M since the same quarter in the previous year.
Finally, its free cash flow grew by 127.4% to $2M since the same quarter in the previous year.
Based on the above factors, VIVO Cannabis Inc gets an overall score of 4/5.